Drug intelligence / Profile preview

UC-MSC infusion

Development stage: Unknown
Lead developer: Asia Cell Therapeutics
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous

Overview

UC-MSC infusion is an allogeneic cell therapy developed by Asia Stem Cell Regenerative Pharmaceutical Co., Ltd. (also known as Asia Cell Therapeutics). The product consists of human umbilical cord-derived mesenchymal stem cells (UC-MSCs) formulated for intravenous administration. It is primarily being investigated for the treatment of decompensated hepatitis B liver cirrhosis, particularly in patients who have failed conservative treatments and are not immediate candidates for liver transplantation. The therapeutic mechanism leverages the innate properties of mesenchymal stem cells, including immunomodulation, anti-fibrotic activity, and the promotion of hepatocyte regeneration and tissue repair. Clinical evaluation focuses on safety and the improvement of liver function indices such as serum albumin levels, bilirubin, and MELD scores.

Other names: human umbilical cord mesenchymal stem cellsumbilical cord mesenchymal stem cell transplantationUmbilical Cord-derived Mesenchymal Stem Cell infusion

Beyond the preview

Go deeper on UC-MSC infusion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UC-MSC infusion.

Explore the full profile